中文名 | Ravuconazole (BMS-207147 ER-30346) |
英文名 | 4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)b utan-2-yl]-1,3-thiazol-4-yl]benzonitrile |
别名 | 里氟康唑 雷氟康唑 立福康唑 立福康唑,雷夫康唑 4-(2-((2R,3R)-3-(2,4-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁烷-2-基)噻唑-4-基)苯甲腈 |
英文别名 | Er-30346 Bms-207147 ER-30346) Aids057176 Bms-207,147 Aids-057176 Ravuconazole (BMS-207147 4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)b utan-2-yl]-1,3-thiazol-4-yl]benzonitrile Benzonitrile, 4-[2-[(1R,2R)-2-(2,4-difluro-phenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]- [R-(R*,R*)]-4-{2-[2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)-propyl]-4-thiazolyl}-benzonitrile |
CAS | 182760-06-1 |
化学式 | C22H17F2N5OS |
分子量 | 437.47 |
密度 | 1.38±0.1 g/cm3(Predicted) |
熔点 | 64-66°C |
沸点 | 674.9±65.0 °C(Predicted) |
比旋光度 | D24 -29.1° (c = 1.03 in methanol) |
酸度系数 | 11.62±0.29(Predicted) |
存储条件 | -20°C Freezer |
体外研究 | Ravuconazole shows a broad spectrum of activity against a wide range of fungi covering Candida spp. , Trichosporon beigelii , C. neoformans and A. fumigatus . The MIC 90 ranges from 0.025 to 0.39 mg/mL.Ravuconazoleshows relatively higher levels of activity against three strains of Candida krusei , with MICs ranging from 0.05 to 0.39 mg/mL.Ravuconazoleshows good activity against T. mentagrophytes , T. rubrum , M. gypseum and M. canis with MICs ranging from 0.05 to 0.39 mg/mL. Ravuconazoleis about two- to four fold more potent than itraconazole and about 40-fold more active than fluconazole against yeasts. Ravuconazoleand itraconazoleare inhibitory to most aspergilli, and against half of the isolates, the activity iscidal. Ravuconazoleand itraconazoleare active, though not cidal, against most hyaline Hyphomycetes , dermatophytes, and the dematiaceous fungi and inactive against Sporothrix schenckii and zygomycetes. |
体内研究 | The maximum concentration of ravuconazole in plasma and the area under the concentration-time curve for ravuconazoleshow good linearity over a range of doses from 2 to 40 mg/kg of body weight. Ravuconazole at a dose of 2.5 mg/kg delays mortality significantly compared with the control treatment.Ravuconazole also shows a substantial therapeutic effect against systemic cryptococcosis. Ravuconazole reduces the numbers of CFU in the lungs significantly compared with the numbers of CFU in the lungs of the controls. In an experimental model of oral candidiasis in rats, ravuconazole reduces the numbers of CFU in oral swabs significantly compared with the numbers of CFU in oral swabs from the controls and is more effective than itraconazole and as effective as fluconazole.. |
上游原料 | (ALPHAS,BETAR)-BETA-(2,4-二氟苯基)-BETA-羟基-ALPHA-甲基-1H-1,2,4-三唑-1-丁腈 2-溴-4'-氰基苯乙酮 861718-85-6 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.286 ml | 11.429 ml | 22.859 ml |
5 mM | 0.457 ml | 2.286 ml | 4.572 ml |
10 mM | 0.229 ml | 1.143 ml | 2.286 ml |
5 mM | 0.046 ml | 0.229 ml | 0.457 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!